Business strategy for healthtech and digital health
The digital health sector faces the complex task of aligning clinical evidence with sustainable commercial models. Cogliva provides the structured workspace needed to transform these technical and regulatory requirements into a runnable digital health strategy.
Industry snapshot
The digital health sector is structured into four primary segments: clinical software, wearable devices, telehealth services, and data analytics. Margin is increasingly found in the integration of these segments rather than in standalone hardware or software sales. The industry is currently moving away from the rapid expansion of the previous decade into a phase of consolidation and evidence-based justification. Success is now defined by the ability to demonstrate a clear return on investment to payers and providers.
Profitability is often lost in the lengthy gap between clinical validation and widespread reimbursement. Companies frequently underperform because they fail to navigate the 'valley of death' where pilot projects fail to scale due to a lack of technical interoperability or misaligned incentives. The cost of customer acquisition remains high, particularly when selling into fragmented global health systems. Sustainable margins are reserved for those who can embed their solutions into the daily workflow of the clinical workforce.
The current period is defined by the integration of generative AI and the maturation of remote patient monitoring. Strategy is no longer just about digitising records but about extracting actionable insights from vast pools of clinical data. Trust and security are the primary currencies as health systems face increased cyber threats. Executives are prioritising strategic resilience, seeking business models that remain viable regardless of shifts in the macroeconomic climate or healthcare policy.
Strategic pressures in this sector
The forces most likely to invalidate assumptions in a plan written last year.
Consolidation of point solutions
Health systems are moving away from fragmented point solutions toward integrated platforms that reduce the cognitive load on clinicians. Technology providers must prove their tools can enter existing workflows without causing friction.
Shift to Value-Based reimbursement
The transition from fee-for-service to value-based care requires digital health firms to share financial risk based on patient outcomes. This necessitates highly accurate predictive analytics and real-world data tracking.
Rigorous regulatory oversight
Regulators are tightening requirements for software as a medical device (SaMD) and data privacy. Compliance is no longer a checklist but a continuous strategic requirement that dictates market entry timelines.
Operational constraints in health systems
Incumbent health providers face mounting financial pressure and staffing shortages. Digital health strategies must focus on workforce productivity and high-yield automation to remain attractive to buyers.
Consumerisation of patient experience
Patients are demanding the same level of convenience in healthcare that they experience in retail or banking. Digital products must balance clinical safety with a seamless, user-centric interface to drive adoption.
Demands for data interoperability
Interoperability mandates require seamless data exchange between different clinical systems. Organisations that cannot integrate with major electronic health record (EHR) systems are being excluded from procurement cycles.
What good strategy looks like in this sector
Clinical-First design logic
A successful strategy must start with the specific clinical problem and the existing provider workflow to avoid building solutions that clinicians ignore.
Reimbursement pathway integration
Planning must account for the specific evidence requirements of payers to ensure the product is actually reimbursable upon launch.
Iterative technical roadmapping
Strategy should include a modular technical architecture that allows for rapid pivots as clinical data and regulatory standards evolve.
Contextual market alignment
Strategic plans must be grounded in the operational reality of the health systems they serve, considering staffing levels and legacy IT constraints.
How the model is changing
Value-Based care orchestration
Fixed fees per patient per month replace transactional volume logic as providers take on financial accountability for clinical results. Success relies on high-fidelity data integration and proactive intervention before acute events occur.
Outcome-as-a-Service
SaaS healthcare providers are moving toward risk-sharing agreements where payment triggers only upon specific clinical milestones or cost savings. This requires deep integration into payer workflows and robust evidence of real-world efficacy.
Device-Plus-Digital integration
Pharmaceutical and MedTech firms are wrapping digital services around physical products to improve adherence and gather longitudinal data. These models shift the focus from a single sale to a continuous therapeutic relationship.
Clinical app marketplaces
Platform providers curate ecosystems of niche clinical apps for health systems, managing the governance and procurement burden. Margin is earned through platform stability and the ability to aggregate data across disparate point solutions.
Signals worth monitoring
- Medicare and medicaid reimbursement code updates
- Regulatory filings for competing AI diagnostics
- Changes in hospital system procurement budgets
- Venture capital funding trends for telehealth
- Patent applications for remote monitoring sensors
- Standardisation updates in FHIR data protocols
Typical challenges and the workflow that addresses them
| Challenge | How the workflow handles it |
|---|---|
| We have plenty of pilot data but struggle to align our clinical outcomes with a sustainable commercial roadmap. | Cogliva uses the strategy diagnostic to identify the gap between technical performance and market viability before moving to the Strategy Workbench. |
| The regional regulatory differences are so vast that our operational context is constantly fragmented. | The organisation context module centralises disparate regulatory and market constraints to ensure the strategy remains compliant across different jurisdictions. |
| We struggle to move from high-level board vision to actual technical implementation tasks. | Cogliva converts the strategy design into a concrete tactical plan that assigns specific ownership and timelines to technical and clinical teams. |
| I am never sure if our market assumptions regarding payer reimbursement are still valid. | The strategic signals monitoring feature alerts leadership when shifts in reimbursement policy or competitor filings threaten the current strategic pillars. |
| Our internal data is siloed and the Management Copilot needs better structure to help us make decisions. | The Management Copilot synthesises cross-functional inputs from the workspace to provide real-time insights during the strategy design phase. |
KPIs that hold the strategy together
Patient Activation Measure (PAM)
This identifies how effectively digital tools engage patients in their own care, which is a leading indicator of clinical outcome improvement.
Integration Density
Measuring how many points of a provider workflow the tool touches helps determine the stickiness and defensive moat of the technology.
Time to Clinical Validation
Speed in moving from prototype to peer-reviewed or regulatory-cleared evidence is critical for securing payer reimbursement.
Gross Margin per Managed Life
This tracks the efficiency of the digital service model as it scales across larger patient populations.
Provider Net Promoter Score (NPS)
High provider satisfaction is essential to overcome the friction of clinical adoption and ensure long-term retention in the health system.
Frequently asked
Where does AI fit into a modern digital health strategy?
AI is most effective when applied to specific administrative or diagnostic bottlenecks where data is abundant and accuracy is measurable. In strategy terms, AI should be used to enhance decision-making through better data synthesis and predictive monitoring. A focus on explainability and clinical safety is essential to gain trust from providers and patients alike.
What are the main barriers to scaling digital health solutions?
Scaling requires a shift from proving clinical validity to proving operational and financial portability. This involves standardising data architecture for interoperability and ensuring the business model can adapt to different payer landscapes. Many firms fail because they cannot replicate the results of a controlled pilot in the messy reality of a large-scale health system.
How does regulation impact digital health strategy design?
Regulatory compliance should be treated as a strategic foundation rather than a late-stage hurdle. Strategy design must incorporate data privacy laws and medical device classifications from the outset to avoid costly pivots. Frequent monitoring of evolving standards like GDPR, HIPAA, and MDR ensures that the organisation remains agile when requirements change.
What is a digital health strategy?
A digital health strategy is a formal plan that outlines how an organisation uses technology to improve clinical outcomes, operational efficiency, and patient experience. It must align technical roadmaps with reimbursement models and regulatory requirements. A strong strategy ensures that digital interventions solve specific clinical bottlenecks rather than just adding technical complexity to existing workflows.
Put this into a strategy your team can run
Start with a diagnostic of your organisation, turn the findings into a business strategy, and keep it live with tactical plans and signals.